INTRODUCTION
============

Telomere maintenance and DNA repair are two essential processes that prevent genome instability and cancer. Telomeres are protective DNA--protein complexes at the end of chromosomes, which in all vertebrates consist of long arrays of TTAGGG repeats and associated proteins. Telomeric nucleoproteins are known as the shelterin complex ([@B16]). Interference with any of the shelterin complex members or with the telomeric sequence itself leads to chromosomal instability and loss of cell viability. In addition to the shelterin complex, many other proteins function at the telomere in processes such as telomere extension and telomere replication. Together these proteins prevent chromosomal instability by promoting telomere maintenance. Nevertheless, telomeric sequences are occasionally lost, resulting in telomere length heterogeneity, which can occur at any telomere in single cells, as observed using quantitative fluorescence in situ hybridization (Q-FISH; [@B30]; [@B54]).

Telomeres resemble fragile sites ([@B42]), which are defined as genomic regions that challenge replication, especially when replication is stressed ([@B20]). There are at least two reasons that telomeres pose problems during replication. First, telomeres are known to form a protective lariat-like structure, referred to as the telomeric (T)-loop ([@B17]), created by invasion of the 3′ single-stranded telomeric DNA end into the duplex region of the telomere repeats. Resolution of the T-loop structure is needed for telomere replication. Second, telomeres are guanine (G) rich and thus are capable of forming stable secondary structures such as guanine quadruplex (G4) DNA structures in vitro ([@B41]). In vivo, G4-DNA could form at the single-strand telomeric overhang, the base of the T-loop, or, more generally, during replication, repair, and transcription of telomeric DNA. At telomeres and other genomic sites of G-rich DNA, replication forks could occasionally stall and, if not properly resolved, result in DNA breaks and sporadic loss of telomeric DNA.

Besides occasional loss of telomeric repeats, telomeric DNA is lost in most proliferating cells because of the inability of the replication machinery to copy the very end of the 3′ template DNA strands. Certain cell types, such as embryonic stem cells (ESCs), cells in the germ line, and cells of highly proliferative tissues, can counteract telomere loss by expressing the reverse transcriptase telomerase that adds telomeric repeats onto the 3′ ends of chromosomes ([@B25]). To prevent telomere shortening and thereby achieve unlimited replicative lifespan, most cancer cells reactivate telomerase, whereas a minority uses alternative lengthening of telomeres (ALT; [@B12]). ALT cells exhibit an increased abundance of extrachromosomal circles of double-stranded telomeric DNA (t-circles), derived from deleterious homologous recombination (HR) events at the T-loop ([@B49]). Recombination-mediated telomere trimming not only takes place in ALT cells, but it is also likely to be involved in telomere maintenance in normal eukaryotic cells ([@B10]; [@B39]).

The average telomere length is determined by the equilibrium between the events that lengthen and shorten telomere arrays. Regulator of telomere length 1 (mRtel1) was found to be a dominant factor in setting telomere length in mice ([@B18]). *mRtel1* encodes an essential DNA helicase, which plays a crucial role in telomere maintenance and DNA repair ([@B48]). Chromosomes with low or undetectable telomere repeats are abundant in mouse ESCs lacking mRtel1 ([@B18]). Furthermore, suppression of *mRtel1* in mouse embryonic fibroblasts (MEFs) increased telomere fragility ([@B42]). In addition to its function in telomere maintenance, human RTEL1 was also found to be involved in the repair of DNA double-strand breaks (DSBs; [@B5]). In vitro, the preferred substrate of RTEL1 is a 3′ single-strand DNA (ssDNA) invaded displacement (D)-loop with a 5′ overhang ([@B53]). In vivo, *Caenorhabditis elegans rtel-1* mutants convert all meiotic DSBs into crossovers, demonstrating that RTEL-1 is required to regulate meiotic recombination in this species ([@B53]). Despite these important insights, the role of mRtel1 in replication, recombination, DNA repair, and telomere maintenance remains incompletely understood.

In this study, we examined the consequences of *mRtel1* deficiency on DNA replication, repair, and recombination, with an emphasis on telomere maintenance. Our results indicate an important role for mRtel1 in replication and the repair of several types of DNA damage. In addition, we show that, depending on the recombination substrate and context, mRtel1 can be either a positive or a negative regulator of HR. Whereas mRtel1 is required for efficient telomere replication in ESCs, we found no evidence for the involvement of mRtel1 in preventing recombination at telomeres. Surprisingly, our data suggest that mRtel1 is required to allow elongation of telomeres by telomerase.

RESULTS
=======

Generation of epitope-tagged and fluorescently tagged *mRtel1* knock-in mice
----------------------------------------------------------------------------

We generated mouse ESCs in which endogenous mRtel1 was replaced with an epitope- and fluorescently tagged mRtel1 fusion protein. Using bacterial artificial chromosome (BAC) recombination-mediated genetic engineering (recombineering; [@B15]), we constructed a targeting vector in which the stop codon in exon 34 was deleted and the *mRtel1* gene was extended with tag sequences ([Figure 1A](#F1){ref-type="fig"}). Insertion of this knock-in targeting vector at the *mRtel1* locus results in the expression of a C-terminally tagged mRtel1 protein at endogenous levels. Correctly targeted clones were identified ([Figure 1B](#F1){ref-type="fig"}), and the fusion protein was expressed ([Figure 1C](#F1){ref-type="fig"}). Subcellular fractioning ([Figure 1D](#F1){ref-type="fig"}) showed that mRtel1 is mainly present in the nucleus.

![Generation and characterization of epitope-tagged and fluorescently tagged *mRtel1* knock-in ESCs. (A) Schematics of the *mRtel1* locus, gene-targeting construct, and targeted locus. The top of the scheme depicts ∼36.6 kb of the mouse *mRtel1* locus. Exons are indicated as black boxes. The second line represents the *mRtel1-tag* targeting construct. Using recombineering, we inserted a multipurpose tag directly 3′ of the gene in front of the termination codon in exon 34. The neomycin resistance marker surrounded by *LoxP* sites is located 3′ of the *mRtel1* 3′ UTR. The mutated genomic locus containing the *mRtel1-tag* fusion is shown at the bottom. The 3′ external probe and diagnostic *Eco*RV (EV) sites are indicated. Genotyping primers are indicated as arrows at the bottom. (B) Southern blot of *Eco*RV-digested genomic DNA of *mRtel1^+/+^* and *mRtel1^+/tag+Neo^* knock-in ESCs. Wild-type and targeted mouse ESCs show the predicted restriction fragments using the probe indicated in A. (C) Immunoblots of *mRtel1^+/+^* and *mRtel1^+/tag^* knock-in ESCs total protein extracts and (D) cytoplasmic and nuclear fractions. mRtel1-tag fusion protein was detected using an anti-FLAG antibody. (E) Fluorescence confocal and transmission images of C-terminally tagged mRtel1 in living *mRtel1^tag/tag^* knock-in ESCs.](2782fig1){#F1}

We then analyzed the localization of fluorescently tagged mRtel1 in *mRtel1^tag/tag^* knock-in ESCs. Using confocal microscopy, we detected a diffuse fluorescence signal in the nucleus ([Figure 1E](#F1){ref-type="fig"}). Fluorescence-activated cell sorting (FACS) analysis of wild-type and *mRtel1^tag/tag^* knock-in ESCs showed a distinct homogeneous population of cells expressing very low levels of tagged-mRtel1 (unpublished data).

Two positively identified clones were injected into C57bl/6J blastocysts to produce chimeric mice that transmitted the targeted *mRtel1* knock-in allele through the germ line. Homozygous *mRtel1^tag/tag^* mice were phenotypically wild type and fertile, and no aberrant phenotype has been observed for up to 1 yr of age. In contrast, previously generated *mRtel1* knockout mice die around day 10 of embryogenesis ([@B18]), demonstrating that mRtel1 is essential for embryonic development.

Therefore we conclude that endogenous mRtel1 protein levels are very low, as demonstrated by microscopy and FACS in *mRtel1^tag/tag^* knock-in ESCs. In addition, we conclude that C-terminally tagged mRtel1 is a functional protein.

mRtel1 is required during replication
-------------------------------------

Highest expression of *mRtel1* mRNA was detected in actively proliferating cells ([@B18]). To investigate whether mRtel1 is required during S phase, we determined the DNA-damage sensitivity of *mRtel1-*deficient ESCs for agents that cause replication fork stalling. Compared to wild-type ESCs, *mRtel1*-deficient cells were more sensitive to aphidicolin ([Figure 2A](#F2){ref-type="fig"}), an agent that inhibits various DNA polymerases. In addition, sensitivity to hydroxyurea (HU), which inhibits ribonucleotide reductase and thus the synthesis of dNTPs, was increased ([Figure 2B](#F2){ref-type="fig"}). An increase in stalled replication forks and DSBs can be measured by the appearance of phosphorylated H2AX (γ-H2AX; [@B38]; [@B43]). We therefore quantified the number γ-H2AX foci in the presence and absence of mRtel1. As depicted in [Figure 2C](#F2){ref-type="fig"}, more γ-H2AX foci per nucleus are present in ESCs lacking mRtel1 compared with wild-type ESCs (p = 0.02). The sensitivity of *mRtel1*-deficient cells to S phase--specific DNA damage and the increase in γ-H2AX foci suggest that mRtel1 is required during replication.

![mRtel1 is required during S phase. (A, B) Sensitivity of wild-type (C1) and two *mRtel1*-deficient (A4 and F2) ESC lines to the indicated doses of aphidicolin (A) and HU (B). Bars, mean percentage values of four experiments with SDs. (C) Analysis of the number of γ-H2AX foci per nucleus in wild-type (C1) and *mRtel1*-deficient (F2) ESCs. Foci in 1200 wild-type and 750 *mRtel1*-deficient nuclei in one focal plane were analyzed. (D) Images from a time-lapse movie of mRtel1-tag-DD expressed in *mRtel1*-deficient (F2) ESCs and cultured in the presence of aphidicolin (2 μM) and shield-1 (1 μM), both added at t = 0. Three image *z*-stacks (2.5-μm spacing) were acquired every hour. Projections of three *z*-stacks are depicted. Scale bar, 10 μm. (E) Colocalization of mRtel1-tag-DD and Cherry-m53BP1-M. Cells were cultured in the presence of aphidicolin (2 μM) and shield-1 (1 μM), and images depicted were taken at 17.5 h. Scale bar, 5 μm.](2782fig2){#F2}

Next we wanted to know the spatial and temporal localization of mRtel1 upon DNA damage affecting replication fork progression. The very low expression level of mRtel1-Venus in the knock-in *mRtel1^tag/tag^* ESCs prevented their use for live-cell imaging studies. Moreover, overexpression of mRtel1 is toxic to mouse ESCs (unpublished data). To circumvent low expression levels and toxicity by constitutive overexpression, we used the inducible, tunable, and reversible Shld1 system ([@B4]). We generated destabilized mRtel1-tag protein by fusing it to a destabilizing domain (DD) and expressed this in *mRtel1*-deficient ESCs. The unfolding and subsequent degradation of mRtel1-tag-DD can be blocked by adding the small, cell-permeable stabilizing molecule Shield-1 to the cell culture media. Using this experimental system, we created a short window in time to overexpress and follow mRtel1-tag-DD. mRtel1-tag-DD is present in the nucleus but can also be detected in the cytoplasm (Supplemental Figure S1 and Supplemental Movie S1). In most cells no mRtel1-tag-DD foci could be detected; however, some cells contained a few foci. On addition of aphidicolin (2 μM), an increase in the number of mRtel1 foci over time was observed ([Figure 2D](#F2){ref-type="fig"} and Supplemental Movie S2). To address whether these mRtel1 foci represent sites of DNA damage, we coexpressed mRtel1-tag-DD and the fluorescently tagged m53BP1 minimum domain (m53BP1-M). m53BP1-M is the essential domain of m53BP1 for DNA damage foci formation ([@B40]). As visualized in [Figure 2E](#F2){ref-type="fig"}, mRtel1 and m53BP1-M did colocalize upon aphidicolin treatment.

Together these results suggest that mRtel1 is required during S phase and, upon persistent replication stress--induced DNA-damage, forms discrete foci that colocalize with the DNA damage marker m53BP1-M.

mRtel1 is involved in DNA repair
--------------------------------

To investigate whether mRtel1 is primarily required for replication or also has a more general role in DNA repair, we determined survival of *mRtel1-*deficient ESCs upon treatment with various DNA-damaging agents that require the involvement of several DNA repair pathways, including HR, nucleotide excision repair (NER), base excision repair (BER), mismatch repair (MR), and translesion synthesis (TLS).

As was shown for *C. elegans rtel-1* mutants and *RTEL1*-depleted human cells ([@B5]), *mRtel1*-deficient ESCs are sensitive to DNA interstrand cross-links (ICLs; [Figure 3A](#F3){ref-type="fig"}). ICLs are complex lesions that interfere with transcription and replication. ICL repair requires many proteins from several DNA repair pathways, including HR, NER, MR, and TLS. On treatment with 1 μg/ml mitomycin C (MMC) for 1 h, mRtel1-tag-DD forms foci (Supplemental Figure S2 and Supplemental Movie S3). The number of foci increases in time and reaches a maximum around 13 h after treatment.

![mRtel1 promotes DNA repair. (A) Sensitivity of wild-type (C1) and two *mRtel1*-deficient (A4 and F2) ESC lines to the indicated doses of MMC. (B) mRtel1-tag-DD colocalizes with FancD2. Cells were cultured in the presence of shield-1 (1 μM) and 1 μg/ml MMC for 24 h and paraformaldehyde fixed. FandD2 was detected by immunofluorescence (ab2187; Abcam). Scale bar, 5 μm. (C, D) Sensitivity of wild-type (C1)*,* two *mRtel1*-deficient (A4 and F2), and *mRad54*-deficient ESC lines to the indicated doses of γ-rays (C) and MMS (D). (E) Sensitivity of wild-type (C1)*, mRtel1*-deficient (A4 and F2), and *mRad17^5′∆/5′∆^* ESC lines to the indicated doses of UV. Bars, mean percentage values of four experiments with SDs.](2782fig3){#F3}

Sensitivity to MMC is characteristic of cells deficient in any of the genes associated with the human disease Fanconi anemia (FA; [@B47]). Fanconi anemia protein D2 (FANCD2) forms DNA repair foci in S phase, which increase in number in response to DNA lesions during replication ([@B22]; [@B46]; [@B28]). On treatment with MMC, we observed many mRtel1 foci, most of which colocalized with mFancD2 ([Figure 3B](#F3){ref-type="fig"}), suggesting that mRtel1 is involved in ICL repair.

*C. elegans rtel-1* mutants and human cells depleted for *RTEL1* are not affected by ionizing radiation ([@B5]). Surprisingly, *mRtel1*-deficient ESCs are more sensitive to γ-rays than are wild-type cells ([Figure 3C](#F3){ref-type="fig"}). As a positive control for γ-radiation, we used radiation-sensitive ESCs deficient for the DNA repair protein mRad54 ([Figure 3C](#F3){ref-type="fig"}).

In addition, we investigated whether *mRtel1* deficiency causes sensitivity to methyl methanesulfonate (MMS) and UV (254 nm) light. MMS lesions are predominantly repaired by BER and alkyltransferases and UV lesions by NER. Unlike MMS-sensitive, *mRad54*-deficient ESCs, the sensitivity of ESCs lacking mRtel1 to MMS-induced lesions was similar to that of wild-type cells ([Figure 3D](#F3){ref-type="fig"}). In contrast, *mRtel1*-deficient ESCs are more sensitive to UV light than are wild-type cells ([Figure 3E](#F3){ref-type="fig"}) but are not as sensitive as *mRad17^5′∆/5′∆^* ESCs.

From these experiments we conclude that mRtel1 is involved in the repair of DNA lesions induced by MMC, γ-radiation, and UV light.

mRtel1 is a key protein in homologous recombination
---------------------------------------------------

Sister chromatid exchanges (SCEs) depend on HR events between sister chromatids during replication ([@B44]; [@B50]). Increased spontaneous SCE is a hallmark of defects in the RecQ family helicase BLM ([@B13]). To investigate whether *mRtel1* deficiency has an effect on SCE frequency, we measured the spontaneous and DNA damage--induced levels of SCEs in wild-type and *mRtel1*-deficient ESCs. Under normal cell culture conditions, SCE frequency in ESCs lacking mRtel1 was more than twice that in wild-type cells ([Figure 4A](#F4){ref-type="fig"}). After mild treatment with MMC (0.04 μg/ml), SCE frequencies increased in both *mRtel1*-deficient and wild-type ESCs but were not significantly different. This finding shows that in the absence of mRtel1, a greater number of DNA strand breaks occurring during DNA replication are repaired using SCE.

![mRtel1 is important for HR. (A) Percentage of spontaneous (black bars) and MMC (0.2 μg/ml, 1 h) induced (white bars) SCEs per metaphase measured in wild-type (C1) and two *mRtel1*-deficient (A4 and F2) ESC lines. Error bars, the 95% confidence interval (CI). (B, C) Gene-targeting efficiency in wild-type (C1) and two *mRtel1*-deficient (A4 and F2) ESC lines at the *mRad54* (B) and *mPim1* (C) loci. Error bars, the SD from four independent experiments.](2782fig4){#F4}

The increase in SCEs suggests that HR between sister chromatids is affected. SCE events, however, only denote crossover recombination when the replication fork is stalled and do not necessarily reflect HR capacity in general. Therefore we also tested the possibility that mRtel1 is involved in the HR subpathway that mediates gene replacement. To assess gene-targeting efficiency in wild-type and *mRtel1*-deficient ESCs, we measured targeting frequencies at the *mRad54* and *mPim1* loci. Targeting frequencies at the *mRad54* locus were measured using a fluorescence-based targeting assay ([Figure 4B](#F4){ref-type="fig"}; [@B1]). Integration of a promoterless *Rad54-GFP* knock-in targeting construct at the *mRad54* locus results in expression of Rad54-GFP from the endogenous promoter, which can be analyzed using flow cytometry. Using this assay, we measured a 40% decrease in targeting efficiency in two independent *mRtel1*-deficient ESC lines tested. Compromised DNA repair as observed in *mRtel1*-deficient ESCs could increase the frequency of breaks and thus stimulate random integration at genomic DNA breaks. However, random integration events were not elevated in wild-type and *mRtel1*-deficient ESCs (unpublished data). In addition to the *mRad54* locus, we tested gene replacement at the *mPim1* locus ([Figure 4C](#F4){ref-type="fig"}; [@B6]). Compared to wild-type cells, targeting frequencies in *mRtel1*-deficient ESCs were 60% reduced.

These gene-targeting experiments demonstrate that mRtel1 plays an important role in HR.

mRtel1 is required for telomere replication and localizes transiently at the telomere
-------------------------------------------------------------------------------------

Next we wanted to address the function of mRtel1 more specifically at the telomere. Mammalian telomeres resemble fragile sites ([@B42]). Just like common fragile sites ([@B24]), these are identified as site-specific breaks or gaps in metaphase chromosomes when treated with low levels of the polymerase inhibitor aphidicolin ([@B42]). Two helicases---BLM and mRtel1---have been implicated in telomere replication in MEFs ([@B42]). To investigate whether mRtel1 is also important for telomere replication in ESCs, we quantified the frequency of fragile telomeres in *mRtel1*-deficient and wild-type ESCs ([Figure 5A](#F5){ref-type="fig"}). In wild-type ESCs the frequency of fragile telomeres was \<1%. However, in *mRtel1* null ESCs, the frequency was 2.5-fold increased, consistent with *mRtel1*-depleted MEFs. Treatment with low levels (0.2 μM) of aphidicolin increased the fragile telomere frequency to nearly 4%, whereas this did not change notably in wild-type cells. These results confirm that mRtel1 is required for telomere replication.

![mRtel1 is required for telomere replication and extension. (A) Analysis of fragile telomeres in wild-type (C1) and *mRtel1*-deficient (F2) ESCs with or without 0.2 μM aphidicolin treatment. Bars, SEM; \*p \< 0.01, \*\*p \< 0.001. (B) Sensitivity of wild-type (C1) and two *mRtel1*-deficient (A4 and F2) ESC lines to the indicated doses of TMPyP4. Bars, mean percentage values of three experiments with SDs. (C) Images from a time-lapse movie of mRtel1-tag-DD and Cherry-mTrf1 coexpressed in *mRtel1*-deficient (F2) ESCs and cultured in the presence of shield-1 (1 μM). Imaging started 72 h post Cherry-mTrf1 transfection. Ten image *z*-stacks (0.5-μm spacing) were acquired every 15 min. Far left, three still images (projection of 10 *z*-stacks) extracted from a time-lapse movie from a single cell acquired at indicated time points. Merge, zooms on the boxed nuclear region of the left images, showing colocalization of mRtel1-tag-DD (third from left) and Cherry-mTrf1 (far right). Scale bar, 5 μm. (D) TRF analysis of wild-type and *mRtel1*-deficient ESCs. 1, Wild type (C1); 2, *mRtel1* deficient (A4); 3, *mRtel1* deficient (E1); 4, *mRtel1* deficient (F2); 5, wild type (C1 subclone 4); 6, *mRtel1* deficient (F2 subclone 11). (E) TRF analysis of wild-type (C1 subclone 4) and *mRtel1*-deficient (F2 subclones 3 and 11) ESCs. DNA was extracted from wild-type and *mRtel1*-deficient clones at t = 0 and after 1, 2, and 3 wk in culture.](2782fig5){#F5}

To obtain further evidence for a role of mRtel1 in telomere replication, we performed a colony-forming assay using wild-type and *mRtel1*-deficient cells treated with increasing concentrations of TMPyP4. TMPyP4 binds strongly to G4-DNA, which is likely to be present at many sites in the genome and is believed to be especially abundant at the telomere. G4-DNA could be normally present at the telomere or arise during lagging-strand replication of G-rich telomeric DNA ([@B18]). Using the colony-forming assay, we found that *mRtel1*-deficient ESCs were more sensitive to TMPyP4 than were wild-type cells ([Figure 5B](#F5){ref-type="fig"}). Sensitivity for TMPyP4 suggests that mRtel1 is required for replication of G4-DNA. However, it is not known whether mRtel1 unwinds G4-DNA in vivo or can resolve G4-DNA structures in vitro.

In the absence of mRtel1, telomeric replication fork stalling and collapse and subsequent breaks in telomeric DNA could occur more frequently than in normal cells. Chromosome ends with low or undetectable telomere repeats are abundant in *mRtel1*-deficient ESCs, suggesting significant telomere loss ([@B18]). To investigate whether telomeres synthesized by leading- and lagging-strand DNA replication were equally affected by *mRtel1* deficiency, we performed chromosome orientation FISH on leading- and lagging-strand telomeres (unpublished data; [@B3]). We did not find an imbalance in leading/lagging-strand signals, and thus we conclude that mRtel1 is required for both leading- and lagging-strand telomere replication.

Because mRtel1 is involved in telomere replication, we investigated telomeric localization of mRtel1. We performed live-cell imaging on *mRtel1*-deficient ESCs coexpressing mRtel1-tag-DD and Cherry-mTrf1 ([Figure 5C](#F5){ref-type="fig"} and Supplemental Movie S4). Using Cherry-mTrf1 as a telomere marker, we looked for colocalization of mRtel1 and mTrf1 foci. In [Figure 5C](#F5){ref-type="fig"}, three time points of a movie are depicted in which overlapping mRtel1 and mTrf1 foci are observed. However, at any given time the majority of mRtel1 and mTrf1 foci do not colocalize, suggesting that mRtel1 localizes transiently at the telomere.

No increase in telomeric recombination in the absence of mRtel1
---------------------------------------------------------------

Next we asked whether unscheduled recombination events could cause the abundance of short telomeres in the absence of mRtel1. Because replication-associated recombination events as measured by genomic-SCEs are elevated in *mRtel1*-deficient ESCs, we investigated whether we could also measure an increase in recombination events at the telomere. Therefore we determined the level of telomeric-SCEs (T-SCEs) using CO-FISH. However, no differences between wild-type and *mRtel1*-deficient cells were found (unpublished data).

In addition, we investigated the possibility of deleterious HR events at the T-loop in the absence of mRtel1. An enzymatic activity of mRtel1 to unwind T-loops would be in line with the in vitro activity of RTEL1: displacing a 3′ ssDNA invaded D-loop with a 5′ overhang ([@B53]), which resembles the telomeric D-loop. Deleterious HR events at the T-loop happen frequently in ALT cells, which can be measured as an increased abundance of t-circles ([@B49]). To investigate whether t-circles were more abundant in *mRtel1*-deficient ESCs compared to wild-type cells, we analyzed telomeric restriction fragments first by size and then by structure using two-dimensional (2D) gel electrophoresis ([@B8]; [@B14]). The subsequent 2D telomere blots showed no differences in the amount of t-circles between the ESC lines (unpublished data). In addition, partially single-stranded telomeric (CCCTAA)~n~ DNA circles have been found to be ALT specific ([@B26]). These circles can be detected using a quantitative c-circle assay. Using this assay, we found no differences in the amount of c-circles between wild-type and *mRtel1*-deficient cells (unpublished data).

Taken together, these results indicate that increased telomeric recombination cannot explain the variable telomere length in ESCs lacking *mRtel1*. Furthermore, these results are in agreement with the fact that average telomere length is maintained for many population doublings in *mRtel1*-deficient ESCs ([@B18]).

Telomeres are functional but not extended in the absence of mRtel1
------------------------------------------------------------------

Very short telomeres, not detectable by Q-FISH, are relatively abundant in *mRtel1*-deficient ESCs ([@B18]). When telomeres are critically short or when telomere maintenance or telomere-protective factors are impaired, this can lead to telomere uncapping. This telomere uncapping results in telomere dysfunction, which is associated with the formation of telomeric DNA damage response factor foci, such as γ-H2AX ([@B45]). To investigate whether telomeres in ESCs lacking mRtel1 were dysfunctional, we quantified the number of telomere dysfunction--induced foci (TIFs), as visualized by the localization of γ-H2AX at the telomere using immuno-FISH in wild-type and *mRtel1*-deficient ESCs. The number of γ-H2AX foci at the telomeres was not different from that in wild-type cells in cells lacking mRtel1 (unpublished data), indicating that the undetectable telomeres by Q-FISH are still capped and appear to be functional.

To gain additional insight into the role of mRtel1 at the telomere, we performed high-resolution terminal restriction fragment (TRF) analysis ([@B29]). Genomic DNA was digested with *Hin*fI/*Rsa*I, *Msp*I/*Rsa*I, and *Mbo*I, resolved using pulsed-field gel electrophoresis, blotted, and probed with a telomeric probe to detect the telomere fragments ([Figure 5D](#F5){ref-type="fig"}). Whereas in wild-type cells the expected telomeric smear representing the heterogeneous telomere length distribution in the ESC population was detected, in cells lacking mRtel1 a striking banding pattern was observed. The observed TRF pattern was independent of the restriction enzymes used, indicating that these are long arrays of telomeric repeats likely not interspersed by other sequences. Therefore the observed banding pattern represents homogeneous telomere length of individual chromosomes within the cell population. From this we conclude that individual telomere length in *mRtel1*-deficient ESCs is fixed even in the presence of telomerase.

To investigate whether the observed TRF banding pattern could be explained by the inability of telomerase to extent the telomeres, we measured telomere length with increasing population doublings. If telomeres cannot be extended by telomerase, a gradual telomere length decline due to the inability of the replication machinery to replicate the end of the chromosome would be expected, just as in telomerase negative cells. As hypothesized, we observed gradual telomere shortening in *mRtel1*-deficient ESCs ([Figure 5E](#F5){ref-type="fig"}) over a 3-wk period. These results suggest that mRtel1 is required for telomere extension in mouse ESCs.

DISCUSSION
==========

In this study, we used mouse ESCs lacking mRtel1 to reveal the importance of mRtel1 in replication, DNA repair, HR, and telomere maintenance.

*mRtel1*-deficient ESCs show a dramatic telomere phenotype, and many chromosomal abnormalities are observed upon differentiation ([@B18]). Furthermore, constitutive overexpression of mRtel1 in ESCs is not tolerated. Because both *mRtel1* deficiency and overexpression give such strong phenotypes, mRtel1 protein levels must be tightly regulated. mRtel1 protein levels are very low, making it difficult to use *mRtel1^tag/tag^* knock-in ESCs for fluorescence imaging. However, since *tagged-mRtel1* knock-in mouse ESCs and mice do not show any of the phenotypes of *mRtel1*-deficient ESCs and mice, we expect C-terminally tagged-mRtel1 to be functional. On the basis of this knowledge, we developed an experimental system in which we expressed inducible, tunable, and reversible mRtel1-Venus in *mRtel1*-deficient ESCs. Using this system, we found that mRtel1 forms foci that increase in number over time upon induction of DNA damage. In addition, these foci colocalize with DNA repair markers, suggesting that mRtel1 is present at sites of active DNA repair.

In accordance with a function of mRtel1 in replication and DNA repair, *mRtel1*-deficient mouse ESCs contain elevated levels of γ-H2AX foci and are sensitive to aphidicolin, hydroxyurea, γ-radiation, MMC, and UV light, which cause different types of DNA lesions. The sensitivity to a variety of DNA-damaging agents suggests that mRtel1 has separate functions in different DNA repair pathways. Alternatively, mRtel1 could be required in a repair step that is shared among a number of DNA repair pathways. In *C. elegans*, RTEL-1 is required for the response to DNA damage affecting replication fork progression ([@B5]). Many DNA-damaging agents form obstacles or breaks in the DNA template that interfere with replication. Because mouse ESCs spend 75% of the cell cycle time in S phase, DNA-damaging agents have a great impact on replication, leading to fork stalling or, when the replisome dissociates, fork collapse. To restart a stalled replication fork or reactivate a collapsed fork, a Holliday junction recombination intermediate might form ([@B37]). mRtel1 might be required for strand displacement after Holliday junction--mediated fork restart. In addition, mRtel1 could prevent broken DNA molecules from invading homologous sequences during replication. Both activities would be in agreement with the reported enzymatic activity of purified human RTEL1 in vitro, which prevents the formation of a D-loop structure and displaces a 3′ ssDNA invaded D-loop with a 5′ overhang ([@B5]; [@B53]).

In line with an antirecombinogenic function of mRtel1 during replication, SCEs were more abundant in the absence of mRtel1. In addition, gene conversion events in *RTEL1*-knockdown HeLa cells were increased fourfold as measured using an I-SceI--inducible DSB assay ([@B5]). Furthermore, all meiotic DSBs created in *C. elegans* are resolved into crossovers in the absence of *rtel-1* ([@B53]). In contrast, ESCs lacking mRtel1 show a twofold decrease in gene-targeting efficiency at the *mRad54* and *mPim1* loci. Opposite outcomes in SCEs and gene-targeting assays have been reported previously. For example, *FANCC*- and *FANCD2*-deficient DT40 cells show an increase in spontaneous SCEs and a decrease in gene-targeting efficiency ([@B34]; [@B27]; [@B52]). In addition, *mErcc1*, *mRad54*, and *mRad17* ESC mutants show reduced gene targeting, whereas SCEs are unaffected ([@B21]; [@B19]; [@B33]; [@B11]). One of the differences of HR between sister chromatids and homologous gene replacement is that SCEs are recombination events associated with replication problems, whereas gene replacement is not. Furthermore, the recombination substrates are different; sister chromatids are identical, whereas gene replacement constructs also contain nonidentical sequences. The mechanism of gene replacement is poorly understood. However, the recombination intermediates in replication fork restart resulting in SCEs and gene replacement are likely to be different. For example, the targeting construct for gene replacement reveals two ssDNA ends after exonucleolytic processing, and invasion by both ends into homologous sequences creates two D-loops. For gene replacement, mRtel1 might be required to resolve a recombination intermediate, resulting in a decreased recombination efficiency in the absence of mRtel1. However, mRtel1 deficiency in the context of replication results in recombination intermediates processed into crossing overs.

In this study we show that mRtel1 is not only required for replication in general as discussed, but also for leading- and lagging-strand telomere replication. Using live-cell imaging, we found that mRtel1 is transiently present at the telomere. It is possible that mRtel1 is recruited to the telomere when the replication machinery stalls. Alternatively, very few mRtel1 molecules, not detectable as foci, could be present at every telomere. On the basis of its preferred substrate in vitro, a 3′ ssDNA invaded D-loop with a 5′ overhang ([@B53]), and the resemblance of this structure with the T-loop, we anticipated that mRtel1 would be required to resolve the T-loop during replication. However, no increase in telomeric HR products, including t-circles and c-circles, were observed in *mRtel1*-deficient cells. Therefore rapid deletion and extension of telomeres due to recombination cannot explain the telomere length phenotype in ESCs lacking mRtel1.

The increased frequency of chromosomes with undetectable telomeric sequences in *mRtel1*-deficient ESCs can be explained, however, by the inability of telomeres to be extended by telomerase. In normal cells, telomeric sequences are occasionally lost, presumably due to stalled replication forks and DNA breakage and possibly due to erroneous deletion of the T-loop by HR. In wild-type ESCs, these telomeres are extended by telomerase. However, in ESCs lacking mRtel1, telomeres cannot be extended, so sporadic telomere deletions accumulate over time, resulting in an increased abundance of very short telomeres in *mRtel1*-deficient cells. The high-resolution TRF confirms this hypothesis. Whereas in wild-type cells a telomeric smear is observed, telomeres of ESCs lacking mRtel1 show a banding pattern. This banding pattern shows that telomere length at individual chromosomes between cells is strikingly uniform. This can be explained by the fact that telomere length was set at the time of fertilization and telomerase was unable to elongate telomeres subsequently. Therefore telomere length gradually decreases in *mRtel1*-deficient ESCs. From this, we hypothesize that in ESCs lacking mRtel1, telomerase has no access or is not recruited to the telomere. In agreement with this hypothesis, *mTerc*-deficient ESCs ([@B35]; [Figure 3](#F3){ref-type="fig"}) and MEFs ([@B7]; [Figure 4, A and B](#F4){ref-type="fig"}) show a TRF banding pattern like ESCs lacking mRtel1.

In summary, the present study provides evidence that mRtel1 is required for a variety of HR-mediated DNA repair processes. *mRtel1*-deficient cells are sensitive to replication inhibitors and are compromised in ICL and DSB repair. In addition, in the absence of mRtel1, gene replacement is less efficient, and SCEs are increased. We hypothesize that mRtel1 is required to resolve a common recombination intermediate in these processes. Our data are in agreement with a role of mRtel1 at stalled or collapsed replication forks by promoting noncrossover repair through the synthesis-dependent strand-annealing subpathway of HR. Furthermore, mRtel1 is transiently present at the telomere and is required for telomere replication and extension in ESCs. It seems possible that recruitment of mRtel1 and telomerase are both transient, for example, via secondary structures at the 3′ end of telomeres that form only rarely. Further experiments will determine whether mRtel1 directly recruits telomerase or promotes telomere accessibility for telomerase.

MATERIALS AND METHODS
=====================

Construction of the *mRtel1*-targeting vector
---------------------------------------------

The *mRtel1*-targeting construct was made using recombineering ([@B31]). Briefly, the end-sequenced 129SvEV/AB2.2 BAC ([@B2]) bMQ-413M4 containing the entire *mRtel1* gene was obtained from the Wellcome Trust Sanger Institute (Cambridge, United Kingdom). The BAC was purified from DH10B cells and electroporated in SW102---the bacterial strain designed for BAC recombineering using *galK* ([@B51]). All primers used are listed in the Supplemental Materials and Methods. The *galK* gene was amplified from plasmid p*galK* using primers 1140/1141 and inserted in the BAC 3′ of the *mRtel1* 3′ untranslated region (UTR) using recombineering. The neomycin gene, expressed both from a prokaryotic (*em7*) and a eukaryotic promoter (PGK) flanked by two *loxP* sites, was PCR amplified using plasmid PL452 and primers 1142/1143. Subsequently, *galK* was replaced by the neomycin gene using recombineering. Similarly, using different primer pairs, we introduced the *tag* sequence (Supplemental Materials and Methods) in exon 34 of *mRtel1* just in front of the termination codon. Next we constructed a retrieval vector to retrieve the targeting sequences from the BAC. Using the *mRtel1*-containing BAC as template and primer pairs 1136/1137 and 1138/1139, we amplified 733 base pairs of the 5′ end and 559 base pairs of the 3′ end of the targeting construct. PCR product 1136/1137 was *Spe*I/*Bam*HI digested, and 1138/1139 was *Bam*HI/*Xba*I digested. These products were subsequently cloned into *Spe*I/*Xba*I--digested plasmid PL253. Next the retrieval vector was digested with *Bam*HI and electroporated into the SW102 containing the modified *mRtel1* BAC. Finally, the BAC sequences between the 5′ and 3′ homology regions were recombined into PL253, resulting in the targeting construct.

Generation and characterization of *mRtel1^+/tag^* ES cells and mice
--------------------------------------------------------------------

IB10 ESCs were electroporated with 20 μg of the *Not*I*-*linearized *mRtel1^tag^* knock-in targeting vector (0.4-cm cuvette, 1200 μF, 118 V). Cells were plated, and 24 h after electroporation cells were selected for 7--10 d using 200 μg/ml G418. After selection, clones were picked and expanded. Homologous targeted clones were identified by Southern blotting using a 3′ probe located outside the targeting vector. The *mRtel1* 3′ probe DNA was amplified by PCR using 129Sv mouse genomic DNA as a template with the following primers: forward, GGCTCTGGGTATTGGATGTGC; reverse, GAACTGCATCTTGAGGACAACACG. This PCR product was ^32^P labeled. Hybridization and washes were performed using standard procedures. Multiple cell lines containing one *mRtel1^tag^* knock-in allele were obtained at a frequency of ∼15%. Subsequently, the neomycin selection marker gene was removed by transient Cre expression. Clones in which the neomycin selection marker was excised were identified by G418 sensitivity and PCR amplification of the remaining *loxP* site. Two positively identified clones were injected into C57bl/6J blastocysts to produce chimeric mice that transmitted the targeted *mRtel1* knock-in allele through the germ line. Male chimeras were bred with C57bl/6J females to produce *mRtel1^+/tag^* offspring. Heterozygous mice were intercrossed to produce homozygous *mRtel1^tag/tag^* mice. Heterozygous *mRtel1^+/tag^* were backcrossed for five generations (N5) to a 129/SvJ background. Subsequently, heterozygous 129/SvJ(N5);*mRtel1^+/tag^* mice were intercrossed, and blastocysts from pregnant females were harvested ([@B9]). Blastocysts were used for the derivation of *mRtel1^+/+^* (wild type), *mRtel1^+/tag^*, and *mRtel1^tag/tag^* ESCs.

Mouse embryonic stem cell lines and culture
-------------------------------------------

Wild-type (C1) and *mRtel1*-deficient (A4, E1, F2; [@B18]) mouse ESCs were obtained from A. Nagy (Samuel Lunenfeld Research Institute, Toronto, Canada) and cultured in the presence of leukemia inhibitory factor (LIF) and 20% fetal calf serum (FCS) on gelatin-coated plastic culture dishes in DMEM containing 20% FCS in the presence of 100 ng/ml LIF as described previously ([@B23]) or in knockout DMEM (10829-018; Life Technologies, Carlsbad, CA) containing 15% Knockout Serum Replacement (10828-028; Life Technologies), 2 mM GlutaMAX-I (35050-038;Life Technologies), 1 mM MEM Non-Essential Amino Acids (11140-035; Life Technologies), 1× penicillin--streptomycin (15140-122; Life Technologies), 0.1 mM 1-Thioglycerol (M6145; Sigma-Aldrich, St. Louis, MO), 3 μM CHIR99021 (Axon 1386; Axon Medchem BV, Groningen, Netherlands), 0.5 μM PD184352 (Axon 1368; Axon Medchem BV), and 1:1000 self-prepared LIF. Aphidicolin (Sigma-Aldrich) treatment (0.2 μM) for fragile telomere analysis was for 16 h.

Plasmids and transfections
--------------------------

The Cherry fluorescent protein was fused to the N-terminus of mTrf1 and m53BP1-M, driven by a *CAG* promoter. *PGK* promoter--driven mRtel1-tag-DD was created by PCR-based cloning as described later. All oligo sequences can be found in the Supplemental Material and Methods. Oligo pair 1810/1811 was used to amplify the *tag* sequence, and the product was subsequently *Mlu*I/*Fse*I digested. Similarly, oligo pair 1812/1813 was used to amplify the FKBP DD coding sequences, and the product was *Fse*I/*Bss*hII digested. Subsequently, these two PCR fragments were ligated into the dephosphorylated *Mlu*I site of *PGK-puro* plasmid. Next *mRtel1* cDNA (Open Biosystems, Thermo Biosystems, Huntsville, AL) was amplified using oligo pair 1814/1815, and the product was *Not*I/*Mlu*I digested. This digested PCR fragment was ligated into *PGK-tag-DD-puro*, giving *PGK-mRtel1-tag-DD-puro*. The mRtel1-tag-DD cell line was generated by transfecting *mRtel1-tag-DD-puro* plasmid DNA into *mRtel1*-deficient (F2) ESCs, and upon 24 h transfection, cells were selected with puromycin (Invitrogen). Transfections were performed using Effectene transfection reagent (Qiagen, Mississauga, Canada) to obtain transient or stable expressing cell lines.

Immunoblot analysis
-------------------

Whole-cell extracts or cyctoplasmic and nuclear protein fractions were separated on 8% SDS-polyacrylamide gels. Subsequently, the separated proteins were transferred onto nitrocellulose membranes (Bio-Rad, Hercules, CA). The mRtel1 fusion protein was detected using a mouse monoclonal anti--FLAG-M2 primary antibody (F1804; 1:4000; Sigma-Aldrich), followed by a secondary antibody coupled to horseradish peroxidase (1:50,000). Immobilized immunoglobulins were visualized using SuperSignal West Pico Chemiluminescent Substrate (Pierce Biotechnology, Rockford, IL).

Cell survival assays
--------------------

Sensitivity of ESCs to various kind of DNA damage was measured as colony-forming ability after exposure to γ-irradiation, MMC (M4287; Sigma-Aldrich), MMS (129925; Sigma-Aldrich), or UV (254 nm) as described ([@B21]). In additional cell survival assays, cells were incubated for 24 h with aphidicolin (A0781; Sigma-Aldrich) or HU (H8627; Sigma-Aldrich) and for 48 h with TMPyP4 (613560; Calbiochem, Merck, Darmstadt, Germany). As positive controls previously published *mRad54*-deficient ESCs ([@B21]) and *mRad17^5′∆/5′∆^* ESCs ([@B11]) were used. All measurements were performed in triplicate. Every experiment was repeated at least three times.

Immunofluorescence and γ-H2AX foci analysis
-------------------------------------------

ESCs were grown on sterilized 0.1% gelatin--coated coverslips. For efficient attachment of ESCs to the glass, coverslips were prepared in the following manner. Dried gelatin-coated coverslips were fixed in 4% paraformaldehyde in phosphate-buffered saline (PBS) for 4 h. Subsequently, coverslips were washed six times in PBS to make sure no traces of paraformaldehyde were left. Cells grown using this method had normal morphology compared with standard gelatin-coated plastic dishes. Cells were fixed in 1% paraformaldehyde in PBS for 15 min and blocked with BSA/glycine. Next fixed cells were incubated with an anti--phospho-histone H2AX (Ser-139) primary antibody (γ-H2AX, clone JBW301; 05-636; used 1:1000; Upstate, Millipore, Billerica, MA) for 2 h and subsequently incubated with a secondary goat anti-mouse Alexa 488 antibody (A-11001; used 1:2000; Invitrogen, Carlsbad, CA) for 1 h. Nuclei were stained with 0.2 μg/ml 4′,6-diamidino-2-phenylindole. Slides were mounted using Prolong Gold Antifade Reagent (P36934; Invitrogen). For γ-H2AX, images were made using a TissueFAX and analyzed using TissueQuest cell analysis software (2010) from TissueGnostics (Tarzana, CA). Experiments were done in triplicate. γ-H2AX foci in at least 750 nuclei per experiment were counted and analyzed using TissueQuest software. For mFancd2 immunofluorescence, fixed cells were incubated with a primary rabbit polyclonal anti-FANCD2 antibody (ab2187; Abcam, Cambridge, MA), which was subsequently detected with a secondary goat anti--rabbit Cy5 antibody.

Confocal and time-lapse microscopy
----------------------------------

Mouse ES cells were plated in \#1.5 Labtek II chambered coverglasses (Nalge Nunc, Rochester, NY). For ESCs to adhere to the glass, the glass was coated with gelatin, air dried, fixed with 4% paraformaldehyde in PBS for 4 h, and rinsed thoroughly with PBS. Time-lapse images were acquired with the DeltaVision RT (Applied Precision, Issaquah, WA) microscope using a 60× Plan Apochromatic/1.4 numerical aperture oil objective (Olympus, Markham, Canada). Confocal microscopy was performed using a LSM 780 and an iLCI Plan-Neofluar 63×/1.3 oil objective (Carl Zeiss, Jena, Germany). ESCs were imaged at 37°C with 5% CO~2~ perfusion.

Gene-targeting assays at the *mRad54* and *mPim1* loci
------------------------------------------------------

Gene targeting to the *mRad54* locus ([@B21]) and measurement and analysis of *Rad54-GFP*--targeting events were performed as described ([@B1]). Briefly, a promoterless *Rad54-GFP* knock-in targeting construct was electroporated into ESCs. Targeted integration of this construct at the *mRad54* locus results in expression of Rad54-GFP from the endogenous promoter ([@B1]). Use of flow cytometry analysis makes it possible to measure homologous integration in individual cells by green fluorescence, and random integration of the construct results in nonfluorescent cells. To measure gene targeting at the *mPim1* locus, we used a *pim-EJ5-GFP*--targeting construct ([@B6]), which was derived from *p59xDR-GFP6* ([@B32]). This targeting construct contains a puromycin-selectable marker and a hygromycin-selectable marker, which is in frame with exon 4 of the *mPim1* gene. For stable integration of *pim-EJ5-GFP*, 75 μg of *Xho*I-linearized DNA was electroporated (0.4-cm cuvette, 250 V, 950 μF) into 1 × 10^7^ ESCs. Subsequently, 48 h after electroporation 10% of the cells were selected in 1.0 μg/ml puromycin and 90% in 110 μg/ml hygromycin. Started clones were counted 6--8 d after selection. Puromycin-resistant clones represent random plus targeted insertion events, whereas hygromycin-positive clones represent correctly targeted clones at the *mPim1* locus.

Sister chromatid exchange assay
-------------------------------

Wild-type and *mRtel1*-deficient ESCs were grown in fresh medium containing 10 μg/ml bromodeoxyuridine (BrdU) for two cell cycles (24--30 h) and were then blocked using 0.1 μg/ml Colcemid (Life Technologies) for 2 h. For MMC treatment, ESCs were incubated with 0.2 μg/ml MMC for 1 h before BrdU incorporation. Subsequently, cells were harvested and swollen in hypotonic buffer (55 mM KCl, 20 mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid, pH 7.4) at 37°C for 5 min and fixed three times in methanol:acetic acid (3:1) buffer, and cells were dropped onto glass slides to obtain metaphase spreads. Differential staining was carried out as described previously ([@B36]). Briefly, metaphase spreads were stained with 150 μg/ml Hoechst 33258 solution, exposed to UV light for 1.5 h, rinsed in 2× saline--sodium citrate (SSC; pH 7.0) at 65°C, dried prior to staining in 2% Giemsa solution (Sigma-Aldrich), and mounted. Brightfield imaging was performed on a Zeiss Axioplan 2 Imaging microscope (Carl Zeiss) equipped with an AxioCam MRm digital camera controlled by Isis software (MetaSystems, Altlussheim, Germany). SCE events were scored on metaphase spreads that showed complete sister chromatid differentiation. The number of metaphases analyzed for spontaneous SCEs were as follows: 47, wild type (C1); 39, *mRtel1* deficient (A4); and 48, *mRtel1* deficient (F2). After MMC treatment the number was as follows: 23, wild type (C1); 25, *mRtel1* deficient (A4); and 39, *mRtel1* deficient (F2).

TRF analysis
------------

TRFs were prepared by digestion with *Hinf*I/*Rsa*I, *Msp*I/*Rsa*I, or *Mbo*I as described previously ([@B39]). Mouse TRFs were separated by one-dimensional pulsed-field gel electrophoresis in a 1% agarose gel for 23 h at 6 V/cm, with an initial switch time of 1 and a final switch time of 6. Gels were dried and denatured and subject to in-gel hybridization overnight using a \[γ-^32^P\]ATP-labeled (CCCTAA)~4~ telomeric probe. Gels were washed in 4× SSC and exposed overnight to a PhosphorImage screen.

Telomere-FISH on metaphase spreads
----------------------------------

Telomere-FISH on methanol/acetic acid--fixed mouse metaphases spreads with a telomeric C-strand peptide nucleic acid probe was performed as previously described ([@B30]; [@B54]).
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